Matsumoto, Yorihiko

写真a

Affiliation

School of Medicine, Department of Surgery (Cardiovascular Surgery) (Shinanomachi)

Position

Instructor
Page Top ▲
 

Papers 【 Display / hide 】

  • Modified composite-graft technique for aortic root replacement

    Matsumoto Y., Joshi Y., Doyle M., Takahara S., Shimizu H., Jansz P.

    General Thoracic and Cardiovascular Surgery (General Thoracic and Cardiovascular Surgery)  71 ( 4 ) 258 - 260 2023.04

    ISSN  18636705

    　View Summary

    This report describes a novel modification of a self-assembled composite graft to replace the aortic root and left ventricular outflow tract (LVOT). This technique enables the implantation of a larger valve than conventional ways and simultaneous reconstruction of LVOT. This technique comprises Inspiris Resilia aortic valve and Gelweave Valsalva graft. By placing the valve in the sinus portion of the graft, the bioprosthesis that is 1 mm smaller than the graft can be accommodated, providing a proper length of the collar for LVOT reconstruction. This technique is useful for patients who require redo-aortic root replacement and have restricted LVOT.

  • Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases

    Joshi Y., Scheuer S., Chew H., Ru Qiu M., Soto C., Villanueva J., Gao L., Doyle A., Takahara S., Jenkinson C., Vaidhya N., Matsumoto Y., Hwang B., Zhao C., Iyer A., Connellan M., Watson A., Granger E., Muthiah K., Jabbour A., Kotlyar E., Keogh A., Bart N.K., Hayward C., Dhital K., Jansz P., Macdonald P.S.

    Transplantation (Transplantation)  107 ( 2 ) 361 - 371 2023.02

    ISSN  00411337

    　View Summary

    Heart transplantation from donation after circulatory death (DCD) donors has the potential to substantially increase overall heart transplant activity. The aim of this report is to review the first 8 y of our clinical heart transplant program at St Vincent's Hospital Sydney, to describe how our program has evolved and to report the impact that changes to our retrieval protocols have had on posttransplant outcomes. Since 2014, we have performed 74 DCD heart transplants from DCD donors utilizing a direct procurement protocol followed by normothermic machine perfusion. Changes to our retrieval protocol have resulted in a higher retrieval rate from DCD donors and fewer rejections of DCD hearts during normothermic machine perfusion. Compared with our previously reported early experience in the first 23 transplants, we have observed a significant reduction in the incidence of severe primary graft dysfunction from 35% (8/23) to 8% (4/51) in the subsequent 51 transplant recipients (P < 0.01). The only withdrawal time interval significantly associated with severe primary graft dysfunction was the asystolic warm ischemic time: 15 (12-17) versus 13 (11-14) min (P < 0.05). One- and 5-y survival of DCD heart transplant recipients was 94% and 88%, comparable to that of a contemporary cohort of donation after brain death recipients: 87 and 81% (P-value was not significant). In conclusion, heart transplantation from DCD donors has become a major contributor to our overall transplant activity accounting for almost 30% of all transplants performed by our program in the last 2 y, with similar DCD and donation after brain death outcomes.

  • Impact of sleep-disordered breathing on ventricular tachyarrhythmias after left ventricular assist device implantation

    Kumai Y., Seguchi O., Mochizuki H., Kimura Y., Iwasaki K., Kuroda K., Nakajima S., Matsumoto Y., Watanabe T., Yanase M., Sata M., Fukushima S., Fujita T., Chikamori T., Kobayashi J., Fukushima N.

    Journal of Artificial Organs (Journal of Artificial Organs)  25 ( 3 ) 223 - 230 2022.09

    ISSN  14347229

    　View Summary

    Sleep-disordered breathing (SDB) is associated with an increased risk of adverse events in patients with heart failure (HF); however, its impact in patients implanted with a left ventricular assist device (LVAD) remains unclear. We aimed to investigate the prevalence of SDB in patients with LVAD and its impact on their clinical outcomes. Fifty consecutive patients with LVAD who underwent portable sleep monitoring between September 2017 and April 2018 were prospectively enrolled, and they were followed up for 170 ± 36 days. According to their respiratory disturbance indexes (RDIs), they were categorized into the SDB group (RDI ≥ 15, n = 12) and the non-SDB group (RDI < 15, n = 38). The incidence of adverse events during the follow-up period was investigated after enrollment. Multivariate logistic regression analysis revealed significant differences in SDB in LVAD-implanted patients in terms of the logarithmic transformation brain natriuretic peptide (BNP) values (p = 0.005). The optimal BNP cut-off value for SDB prediction in LVAD-implanted patients was 300 pg/mL (sensitivity: 58.3%, specificity: 94.7%). During follow-up, ventricular tachyarrhythmias (VTas) occurred significantly more frequently in the SDB group (4 [33%] vs. 2 [5%] patients, p = 0.02); Atrial tachyarrhythmia (ATa) also tended to occur more frequently in the SDB group (2 [25%] vs. 2 [2%] patients, p = 0.07). SBD was prevalent in 24% of the LVAD-implanted patients with advanced HF. Furthermore, SDB was significantly associated with high BNP levels and was also potentially associated with subsequent incidence of VTa in patients with LVAD.

  • Sex differences in continuous-flow ventricular assist device therapy for advanced heart failure

    Matsumoto Y., Fukushima S., Shimahara Y., Tadokoro N., Kakuta T., Kobayashi J., Fujita T.

    General Thoracic and Cardiovascular Surgery (General Thoracic and Cardiovascular Surgery)  69 ( 6 ) 919 - 925 2021.06

    ISSN  18636705

    　View Summary

    Objective: The effect of patient sex in continuous-flow ventricular assist device (c-VAD) therapy has not been well described. We investigated sex-specific differences in clinical outcomes related to c-VAD therapy for Japanese patients. Methods: We retrospectively analyzed 153 patients, including 41 (27%) female patients who underwent c-VAD implantation over the last 13 years in our institution for a mean follow-up of 766 ± 446 days. Clinical outcomes were compared between male and female patients Results: There was no significant difference in mortality, cerebral vascular accidents, the severity of heart failure, or driveline infection in patients who underwent c-VAD implantation, regardless of sex. While male patients tended to have more bleeding at the time of surgery, female patients had significantly higher rates of non-surgical bleeding during subsequent c-VAD therapy, mainly from gynecological origins. Conclusions: Female patients treated with c-VAD had a significantly higher incidence of non-surgical bleeding events. Careful attention to gynecological complications and sex-specific care is required in female patients with c-VAD.

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Page Top ▲
 

Courses Taught 【 Display / hide 】

  • ADVANCED MEDICAL TECHNOLOGIES

    2025

  • ADVANCED MEDICAL TECHNOLOGIES

    2024

  • ADVANCED MEDICAL TECHNOLOGIES

    2023

Page Top ▲